Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis

Clinical Genetics
S D AvakianA P Mansura

Abstract

Hypercholesterolemia has been related to aortic valve stenosis (AS). Polymorphisms of apolipoproteins (apo) AI, B, and E are associated with variable levels of plasma lipids, but the association between these polymorphisms and AS is unknown. In a case-control study of groups matched by age, sex, comparable body mass index, hypertension, triglycerides, high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol, we analyzed the distribution of apo AI A/G mutation, apo B signal peptide insertion/deletion, apo B XbaI restriction fragment length. and apo E polymorphisms in 62 non-diabetic patients with severe aortic valve stenosis and 62 control subjects. All patients underwent echocardiographic analysis. Univariate analysis showed a higher prevalence of the XbaI X + /X + genotype (p = 0.007) of apo B and the apo E2 allele (p = 0.034) in patients with severe AS. Apo polymorphisms were not associated with lipid levels, left ventricular mass, or the aortic gradient.

References

Apr 15, 1987·The American Journal of Cardiology·D LevyW P Castelli
Apr 1, 1993·Journal of the American College of Cardiology·M LindroosR Tilvis
Apr 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·K D O'BrienC M Otto
Mar 1, 1997·Journal of the American College of Cardiology·B F StewartC M Otto
May 14, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·M OlssonJ Nilsson
Dec 11, 1999·American Journal of Nephrology·J S ParkS J Park

❮ Previous
Next ❯

Citations

Oct 27, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Nalini M Rajamannan
Nov 22, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Nalini M Rajamannan
Sep 21, 2011·Future Cardiology·Elena LadichRenu Virmani
Jun 17, 2008·Expert Opinion on Therapeutic Targets·Konstantinos TziomalosDimitri P Mikhailidis
Nov 16, 2016·Scientific Reports·Wenshuo WangLai Wei
Apr 26, 2007·Nature Clinical Practice. Cardiovascular Medicine·Nalini M RajamannanShahbudin H Rahimtoola
Oct 9, 2007·Current Opinion in Cardiology·Luis M MouraNalini M Rajamannan
Apr 14, 2007·Current Cardiology Reports·Nalini M Rajamannan
Jun 7, 2014·Molecular Biology Reports·Anton G KutikhinOlga L Barbarash
Oct 30, 2007·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Kevin D O'Brien
May 20, 2021·The American Journal of Cardiology·Emily HiltnerUNKNOWN Myocardial Infarction Data Acquisition System (MIDAS 41) study group
Oct 8, 2003·Circulation·Gian M NovaroBrian P Griffin
Apr 5, 2008·Journal of the American College of Cardiology·Yohan BosséPhilippe Pibarot
Aug 23, 2011·The American Journal of Cardiology·Nathalie GaudreaultYohan Bossé

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.